Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 1;21(9):2661-2665.
doi: 10.31557/APJCP.2020.21.9.2661.

Clinical Significance of Annexin A4 as a Biomarker in the Early Diagnosis of Hepatocellular Carcinoma

Zienab M Saad  1 , Yasser Fouad  1 , Lamia H Ali  2 , Taha M Hassanin  1
Affiliations

Clinical Significance of Annexin A4 as a Biomarker in the Early Diagnosis of Hepatocellular Carcinoma

Zienab M Saad et al. Asian Pac J Cancer Prev. .

Abstract

Background: Hepatocellular carcinoma (HCC) is one of the most prevalent cancer worldwide. Early detection of HCC is crucial to improve prognosis and survival. Nearly 30 % of HCC patients present with normal serum alpha fetoprotein (AFP), which highlights the need for new biomarkers for HCC. Annexin A4 (ANXA4) is one of the annexin family with high expressions found in gastric, liver, lung, colorectal and ovarian cancers.

Aim: to evaluate the clinical significance of ANXA4 in the early diagnosis of HCC.

Methods: Thirty patients with hepatitis C virus (HCV) related HCC were enrolled in this study. They were stage A according to Barcelona Clinic Liver Cancer (BCLC) staging and they were grade A or B according to Child Pugh Classification. Twenty patients with HCV-related liver cirrhosis and 20 healthy persons seronegative for both HCV and HBV served as control group. ANXA4 and AFP were measured in serum of all cases.

Results: Serum ANXA4 level was significantly higher in HCC patients compared to patients with liver cirrhosis and healthy controls (188, IQR 42-428 and 23, IQR 24-33 and and 21, IQR 22-24 ng ̷ ml, respectively). By using the ROC curve, the area under the curve of ANXA4 was 0.972 and the best cut-off value was115 ng/ml, with sensitivity 95% and specificity 80%.

Conclusion: The serum level of ANXA4 might be a good biomarker for the early detection of HCC.<br />.

Keywords: hepatocellular carcinoma, hepatitis C virus; tumor markers, Annexin A4, Alpha-fetoprotein.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Comparison between the 3 Studied Groups Regarding Serum Level of ANXA4 and AFP
Figure 2
Figure 2
Correlation between Serum Level of AFP and ANXA4 in HCC Group
Figure 3.
Figure 3.
Receiver Operating Characteristic Curve (ROC) Analysis Shows the Diagnostic Performance of ANXA4 and AFP in Discriminating Patients with Hepatocellular Carcinoma from Those with Liver Cirrhosis
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Bharadwaj A, Bydoun M, Holloway R, Waisman D. Annexin A2 heterotetramer: structure and function. Int J Mol Sci. 2013;14:6259–6305. - PMC - PubMed
    1. Bolog N, Andreisek G, Oancea I, Mangrau A. CT and MR imaging of hepatocellular carcinoma. J Gastrointestin Liver Dis. 2011;20:181–9. - PubMed
    1. Bosch FX, Ribes J, Borràs J. Epidemiology of primary liver cancer. Semin Liver Dis. 1999;19:271–85. - PubMed
    1. Chen W, Chen L, Cai Z, et al. Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma. Tumor Biol. 2016;37:9343–55. - PubMed
    1. El-Ghitany EM. Hepatitis C Virus Infection in Egypt: Current Situation and Future Perspective. J High Institut Public Health. 2019;49:1–9.